Clinical Features of Rheumatoid Arthritis

Kelley and Firestein's Textbook of Rheumatology: Volumes 1-2, Tenth Edition

Volumn 2, Issue , 2016, Pages 1167-1186

  Erickson, Alan R ^a   Cannella, Amy C ^b   Mikuls, Ted R ^c  

^a UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85166527393     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-31696-5.00070-X     Document Type: Chapter

References (118)

1. AJ Silman (2001) Rheumatoid arthritis. ed 4 St. Louis: Mosby Elsevier
2. A Del Puente, WC Knowler, DJ Pettitt, et al. (1989) High incidence and prevalence of rheumatoid arthritis in Pima Indians. Am J Epidemiol 129(6), 1170-1178.
3. J Harvey, M Lotze, MB Stevens, et al. (1981) Rheumatoid arthritis in a Chippewa Band. I. Pilot screening study of disease prevalence. Arthritis Rheum 24(5), 717-721.
4. AJ Silman, W Ollier, S Holligan, et al. (1993) Absence of rheumatoid arthritis in a rural Nigerian population. J Rheumatol 20(4), 618-622.
5. MF Doran, GR Pond, CS Crowson, et al. (2002) Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum 46(3), 625-631.
6. E Myasoedova, CS Crowson, HM Kremers, et al. (2010) Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum 62(6), 1576-1582.
7. CS Crowson, EL Matteson, E Myasoedova, et al. (2011) The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum 63(3), 633-639.
8. KL Dominick, FM Ahern, CH Gold, et al. (2004) Health-related quality of life among older adults with arthritis. Health Qual Life Outcomes 2 5.
9. K Eberhardt, BM Larsson, K Nived, et al. (2007) Work disability in rheumatoid arthritis–development over 15 years and evaluation of predictive factors over time. J Rheumatol 34(3), 481-487.
10. H Birnbaum, C Pike, R Kaufman, et al. (2010) Societal cost of rheumatoid arthritis patients in the US. Curr Med Res Opin 26(1), 77-90.
11. VY Ma, L Chan and KJ Carruthers (2014) Incidence, prevalence, costs, and impact on disability of common conditions requiring rehabilitation in the United States: stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, osteoarthritis, rheumatoid arthritis, limb loss, and back pain. Arch Phys Med Rehabil 95(5), 986-995. e981
12. TR Mikuls (2003) Co-morbidity in rheumatoid arthritis. Best Pract Res Clin Rheumatol 17(5), 729-752.
13. MM Ward (2001) Recent improvements in survival in patients with rheumatoid arthritis: better outcomes or different study designs? Arthritis Rheum 44(6), 1467-1469.
14. SE Gabriel, CS Crowson, HM Kremers, et al. (2003) Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum 48(1), 54-58.
15. JH Humphreys, J van Nies, J Chipping, et al. (2014) Rheumatoid factor and anti-citrullinated protein antibody positivity, but not level, are associated with increased mortality in patients with rheumatoid arthritis: results from two large independent cohorts. Arthritis Res Ther 16(6), 483.
16. TR Mikuls, BT Fay, K Michaud, et al. (2011) Associations of disease activity and treatments with mortality in men with rheumatoid arthritis: results from the VARA registry. Rheumatology 50(1), 101-109.
17. A Gonzalez, H Maradit Kremers, CS Crowson, et al. (2007) The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum 56(11), 3583-3587.
18. HK Choi, MA Hernan, JD Seeger, et al. (2002) Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 359(9313), 1173-1177.
19. J Sokolove, R Bromberg, KD Deane, et al. (2012) Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS One 7(5), e35296.
20. KD Deane, CI O'Donnell, W Hueber, et al. (2010) The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner. Arthritis Rheum 62(11), 3161-3172.
21. MK Demoruelle, KD Deane and VM Holers (2014) When and where does inflammation begin in rheumatoid arthritis? Curr Opin Rheumatol 26(1), 64-71.
22. A Krabben, W Stomp, DM van der Heijde, et al. (2013) MRI of hand and foot joints of patients with anticitrullinated peptide antibody positive arthralgia without clinical arthritis. Ann Rheum Dis 72(9), 1540-1544.
23. MG van de Sande, MJ de Hair, C van der Leij, et al. (2011) Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase. Ann Rheum Dis 70(5), 772-777.
24. L Padyukov, C Silva, P Stolt, et al. (2004) A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum 50(10), 3085-3092.
25. TR Mikuls, JB Payne, F Yu, et al. (2014) Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis. Arthritis Rheumatol 66(5), 1090-1100.
26. H Kokkonen, M Mullazehi, E Berglin, et al. (2011) Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis. Arthritis Res Ther 13(1), R13.
27. MK Demoruelle, MH Weisman, PL Simonian, et al. (2012) Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity? Arthritis Rheum 64(6), 1756-1761.
28. JU Scher, C Ubeda, M Equinda, et al. (2012) Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis Rheum 64(10), 3083-3094.
29. CA Hitchon, F Chandad, ED Ferucci, et al. (2010) Antibodies to porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives. J Rheumatol 37(6), 1105-1112.
30. TR Mikuls, GM Thiele, KD Deane, et al. (2012) Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk of rheumatoid arthritis. Arthritis Rheum 64(11), 3522-3530.
31. JU Scher, A Sczesnak, RS Longman, et al. (2013) Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. eLife 2 e01202.
32. E Berglin and SR Dahlqvist (2013) Comparison of the 1987 ACR and 2010 ACR/EULAR classification criteria for rheumatoid arthritis in clinical practice: a prospective cohort study. Scand J Rheumatol 42(5), 362-368.
33. T Neogi, D Aletaha, AJ Silman, et al. (2010) The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: phase 2 methodological report. Arthritis Rheum 62(9), 2582-2591.
34. L Kennish, M Labitigan, S Budoff, et al. (2012) Utility of the new rheumatoid arthritis 2010 ACR/EULAR classification criteria in routine clinical care. BMJ Open 2(5), e001117.
35. N Ichikawa, A Taniguchi, S Kobayashi, et al. (2012) Performance of hands and feet radiographs in differentiation of psoriatic arthritis from rheumatoid arthritis. Int J Rheum Dis 15(5), 462-467.
36. FA van Gaalen, SP Linn-Rasker, WJ van Venrooij, et al. (2004) Auto­antibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum 50(3), 709-715.
37. A Fleming, JM Crown and M Corbett (1976) Early rheumatoid disease. I. Onset. Ann Rheum Dis 35(4), 357-360.
38. C Terao, M Hashimoto, K Yamamoto, et al. (2013) Three groups in the 28 joints for rheumatoid arthritis synovitis–analysis using more than 17,000 assessments in the KURAMA database. PLoS One 8(3), e59341.
39. CC Mok and YK Kwan (2003) Rheumatoid-like polyarthritis as a presenting feature of metastatic carcinoma: a case presentation and review of the literature. Clin Rheumatol 22(4–5), 353-354.
40. PA Guerne and MH Weisman (1992) Palindromic rheumatism: part of or apart from the spectrum of rheumatoid arthritis. Am J Med 93(4), 451-460.
41. Y Emad, A Anbar, I Abo-Elyoun, et al. (2014) In palindromic rheumatism, hand joint involvement and positive anti-CCP antibodies predict RA development after 1 year of follow-up. Clin Rheumatol 33(6), 791-797.
42. WH de Haas, W de Boer, F Griffioen, et al. (1973) Rheumatoid arthritis, typus robustus. Ann Rheum Dis 32(1), 91-92.
43. K Prasad, D Rath and BK Kundu (2014) Arthritis Robustus: review of a case of an “abnormal” rheumatoid. SpringerPlus 3 606.
44. A Sayah and JC English 3rd (2005) Rheumatoid arthritis: a review of the cutaneous manifestations. J Am Acad Dermatol 53(2), 191-209. quiz 210–212
45. MH Ginsberg, HK Genant, TF Yu, et al. (1975) Rheumatoid nodulosis: an unusual variant of rheumatoid disease. Arthritis Rheum 18(1), 49-58.
46. A Fischer, JJ Solomon, RM du Bois, et al. (2012) Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease. Respir Med 106(7), 1040-1047.
47. DE Hastings and JA Evans (1975) Rheumatoid wrist deformities and their relation to ulnar drift. J Bone Joint Surg Am 57(7), 930-934.
48. R Merza Hand deformities in patients with rheumatoid arthritis. http://www.iasj.net/iasj?func=fulltext&aId=52001 Available at
49. RG Gray and NL Gottlieb (1977) Hand flexor tenosynovitis in rheumatoid arthritis. Prevalence, distribution, and associated rheumatic features. Arthritis Rheum 20(4), 1003-1008.
50. OJ V-J (1958) Attritional Rupture of tendons in the rheumatoid hand (abstract). J Bone Joint Surg Am 40A 1431.
51. L Williamson, A Mowat and P Burge (2001) Screening for extensor tendon rupture in rheumatoid arthritis. Rheumatology 40(4), 420-423.
52. L Mannerfelt and O Norman (1969) Attrition ruptures of flexor tendons in rheumatoid arthritis caused by bony spurs in the carpal tunnel. A clinical and radiological study. J Bone Joint Surg Br 51(2), 270-277.
53. H Bienenstock (1975) Rheumatoid plantar synovial cysts. Ann Rheum Dis 34(1), 98-99.
54. MR Rask (1978) Achilles tendon rupture owing to rheumatoid disease. Case report with a nine-year follow-up. JAMA 239(5), 435-436.
55. AF Joaquim and S Appenzeller (2014) Cervical spine involvement in rheumatoid arthritis—a systematic review. Autoimmun Rev 13(12), 1195-1202.
56. MJ Kauppi, MH Neva, K Laiho, et al. (2009) Rheumatoid atlantoaxial subluxation can be prevented by intensive use of traditional disease modifying antirheumatic drugs. J Rheumatol 36(2), 273-278.
57. DN Collins, CL Barnes and RL Fitz Randolph (1991) Cervical spine instability in rheumatoid patients having total hip or knee arthroplasty. Clin Orthop Relat Res 272 127-135.
58. K Ennevaara (1967) Painful shoulder joint in rheumatoid arthritis. A clinical and radiological study of 200 cases, with special reference to arthrography of the glenohumeral joint. Acta Rheumatol Scand (Suppl 11), 11-116.
59. PS Rose, NU Ahn, HP Levy, et al. (2001) The hip in Stickler syndrome. J Pediatr Orthop 21(5), 657-663.
60. C Turesson, L Jacobsson and U Bergstrom (1999) Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology 38(7), 668-674.
61. D Sugiyama, K Nishimura, K Tamaki, et al. (2010) Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 69(1), 70-81.
62. CG Jackson, RL Chess and JR Ward (1984) A case of rheumatoid nodule formation within the central nervous system and review of the literature. J Rheumatol 11(2), 237-240.
63. L Sokoloff (1963) The pathophysiologyof peripheal blood vessels in collagen diseases. Baltimore: Williams & Wilkins
64. F Falcini, G Taccetti, M Ermini, et al. (1997) Methotrexate-associated appearance and rapid progression of rheumatoid nodules in systemic-onset juvenile rheumatoid arthritis. Arthritis Rheum 40(1), 175-178.
65. P Wolf, J Gretler, F Aglas, et al. (1994) Anticardiolipin antibodies in rheumatoid arthritis: their relation to rheumatoid nodules and cutaneous vascular manifestations. Br J Dermatol 131(1), 48-51.
66. E Myasoedova, CS Crowson, C Turesson, et al. (2011) Incidence of extraarticular rheumatoid arthritis in Olmsted County, Minnesota, in 1995-2007 versus 1985-1994: a population-based study. J Rheumatol 38(6), 983-989.
67. BA Michel, DA Bloch and JF Fries (1991) Predictors of fractures in early rheumatoid arthritis. J Rheumatol 18(6), 804-808.
68. BA Michel, DA Bloch, F Wolfe, et al. (1993) Fractures in rheumatoid arthritis: an evaluation of associated risk factors. J Rheumatol 20(10), 1666-1669.
69. A Kleyer and G Schett (2014) Arthritis and bone loss: a hen and egg story. Curr Opin Rheumatol 26(1), 80-84.
70. G Schett and SL Teitelbaum (2009) Osteoclasts and arthritis. J Bone Miner Res 24(7), 1142-1146.
71. U Harre, D Georgess, H Bang, et al. (2012) Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest 122(5), 1791-1802.
72. A Dusad, MJ Duryee, AT Shaw, et al. (2014) Induction of bone loss in DBA/1J mice immunized with citrullinated autologous mouse type II collagen in the absence of adjuvant. Immunol Res 58(1), 51-60.
73. JT Halla, WJ Koopman, S Fallahi, et al. (1984) Rheumatoid myositis. Clinical and histologic features and possible pathogenesis. Arthritis Rheum 27(7), 737-743.
74. M Farr, DL Scott, TJ Constable, et al. (1983) Thrombocytosis of active rheumatoid disease. Ann Rheum Dis 42(5), 545-549.
75. G Campion, PJ Maddison, N Goulding, et al. (1990) The Felty syndrome: a case-matched study of clinical manifestations and outcome, serologic features, and immunogenetic associations. Medicine 69(2), 69-80.
76. N Dwivedi, J Upadhyay, I Neeli, et al. (2012) Felty's syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin traps. Arthritis Rheum 64(4), 982-992.
77. TP Loughran Jr (1993) Clonal diseases of large granular lymphocytes. Blood 82(1), 1-14.
78. SJ Bowman, M Sivakumaran, N Snowden, et al. (1994) The large granular lymphocyte syndrome with rheumatoid arthritis. Immunogenetic evidence for a broader definition of Felty's syndrome. Arthritis Rheum 37(9), 1326-1330.
79. B Combe, M Andary, J Caraux, et al. (1986) Characterization of an expanded subpopulation of large granular lymphocytes in a patient with rheumatoid arthritis. Arthritis Rheum 29(5), 675-679.
80. E Baecklund, A Ekbom, P Sparen, et al. (1998) Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study. BMJ 317(7152), 180-181.
81. G Gridley, JH Klippel, RN Hoover, et al. (1994) Incidence of cancer among men with the Felty syndrome. Ann Intern Med 120(1), 35-39.
82. AE Voskuyl, AH Zwinderman, ML Westedt, et al. (1996) Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study. Ann Rheum Dis 55(3), 190-192.
83. C Bartels, C Bell, A Rosenthal, et al. (2009) Decline in rheumatoid vasculitis prevalence among US veterans: a retrospective cross-sectional study. Arthritis Rheum 60(9), 2553-2557.
84. DL Conn, FC McDuffie and PJ Dyck (1972) Immunopathologic study of sural nerves in rheumatoid arthritis. Arthritis Rheum 15(2), 135-143.
85. AJ Geirsson, G Sturfelt and L Truedsson (1987) Clinical and serological features of severe vasculitis in rheumatoid arthritis: prognostic implications. Ann Rheum Dis 46(10), 727-733.
86. C Turesson, WM O'Fallon, CS Crowson, et al. (2002) Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 29(1), 62-67.
87. M Fischer, H Mielke, S Glaefke, et al. (1984) Generalized vasculopathy and finger blood flow abnormalities in rheumatoid arthritis. J Rheumatol 11(1), 33-37.
88. AL Smitten, TA Simon, MC Hochberg, et al. (2008) A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis. Arthritis Res Ther 10(2), R45.
89. JK Dawson, NG Goodson, DR Graham, et al. (2000) Raised pulmonary artery pressures measured with Doppler echocardiography in rheumatoid arthritis patients. Rheumatology 39(12), 1320-1325.
90. CS Sassoon, SW McAlpine, DP Tashkin, et al. (1984) Small airways function in nonsmokers with rheumatoid arthritis. Arthritis Rheum 27(11), 1218-1226.
91. WH Dodson and JW Hollingsworth (1966) Pleural effusion in rheumatoid arthritis. Impaired transport of glucose. N Engl J Med 275(24), 1337-1342.
92. T Bongartz, C Nannini, YF Medina-Velasquez, et al. (2010) Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum 62(6), 1583-1591.
93. CA Kelly, V Saravanan, M Nisar, et al. (2014) Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics–a large multicentre UK study. Rheumatology 53(9), 1676-1682.
94. ST Frank, JG Weg, LE Harkleroad, et al. (1973) Pulmonary dysfunction in rheumatoid disease. Chest 63(1), 27-34.
95. A Caplan (1953) Certain unusual radiological appearances in the chest of coal-miners suffering from rheumatoid arthritis. Thorax 8(1), 29-37.
96. SH Constantopoulos, EV Tsianos and HM Moutsopoulos (1992) Pulmonary and gastrointestinal manifestations of Sjogren's syndrome. Rheum Dis Clin North Am 18(3), 617-635.
97. EC Ferguson and EA Berkowitz (2012) Lung CT: Part 2, the interstitial pneumonias–clinical, histologic, and CT manifestations. AJR Am J Roentgenol 199(4), W464-W476.
98. C Nannini, YF Medina-Velasquez, SJ Achenbach, et al. (2013) Incidence and mortality of obstructive lung disease in rheumatoid arthritis: a population-based study. Arthritis Care Res 65(8), 1243-1250.
99. KN Shenberger, AR Schned and TH Taylor (1984) Rheumatoid disease and bronchogenic carcinoma–case report and review of the literature. J Rheumatol 11(2), 226-228.
100. JA Avina-Zubieta, HK Choi, M Sadatsafavi, et al. (2008) Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 59(12), 1690-1697.
101. L Levy, B Fautrel, T Barnetche, et al. (2008) Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients. A systematic review of the literature. Clin Exp Rheumatol 26(4), 673-679.
102. PJ Nicola, H Maradit-Kremers, VL Roger, et al. (2005) The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum 52(2), 412-420.
103. DH Solomon, NJ Goodson, JN Katz, et al. (2006) Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis 65(12), 1608-1612.
104. ID del Rincon, K Williams, MP Stern, et al. (2001) High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 44(12), 2737-2745.
105. NJ Goodson, DP Symmons, DG Scott, et al. (2005) Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort. Arthritis Rheum 52(8), 2293-2299.
106. DP Symmons and SE Gabriel (2011) Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol 7(7), 399-408.
107. G Tomasson, T Aspelund, T Jonsson, et al. (2010) Effect of rheumatoid factor on mortality and coronary heart disease. Ann Rheum Dis 69(9), 1649-1654.
108. FJ Lopez-Longo, D Oliver-Minarro, I de la Torre, et al. (2009) Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis. Arthritis Rheum 61(4), 419-424.
109. J Sokolove, MJ Brennan, O Sharpe, et al. (2013) Brief report: citrullination within the atherosclerotic plaque: a potential target for the anti-citrullinated protein antibody response in rheumatoid arthritis. Arthritis Rheum 65(7), 1719-1724.
110. WJ MacDonald Jr, MH Crawford, JH Klippel, et al. (1977) Echocardiographic assessment of cardiac structure and function in patients with rheumatoid arthritis. Am J Med 63(6), 890-896.
111. M Ahern, JV Lever and J Cosh (1983) Complete heart block in rheumatoid arthritis. Ann Rheum Dis 42(4), 389-397.
112. M Wislowska, S Sypula and I Kowalik (1999) Echocardiographic findings and 24-h electrocardiographic Holter monitoring in patients with nodular and non-nodular rheumatoid arthritis. Rheumatol Int 18(5–6), 163-169.
113. JM Iveson, U Thadani, M Ionescu, et al. (1975) Aortic valve incompetence and replacement in rheumatoid arthritis. Ann Rheum Dis 34(4), 312-320.
114. JP Camilleri, AG Douglas-Jones and MH Pritchard (1991) Rapidly progressive aortic valve incompetence in a patient with rheumatoid arthritis. Br J Rheumatol 30(5), 379-381.
115. MP van der Linden, S le Cessie, K Raza, et al. (2010) Long-term impact of delay in assessment of patients with early arthritis. Arthritis Rheum 62(12), 3537-3546.
116. G Mouterde, C Lukas, I Logeart, et al. (2011) Predictors of radiographic progression in the ESPOIR cohort: the season of first symptoms may influence the short-term outcome in early arthritis. Ann Rheum Dis 70(7), 1251-1256.
117. P Weidmann and G Keusch (1977) Treatment of therapy-resistant hypertension. Schweiz Med Wochenschr 107(31), 1081-1093.
118. TR Mikuls, PR Padala, HR Sayles, et al. (2013) Prospective study of posttraumatic stress disorder and disease activity outcomes in US veterans with rheumatoid arthritis. Arthritis Care Res 65(2), 227-234.